Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Haleos Labs Ltd

NSE: HALEOSLABS · BSE: 540679 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹1,584.00
Market cap
₹478.9 Cr
Revenue (annual)
₹333.8 Cr
Net profit (annual)
₹17.31 Cr
P/E (TTM)
30.3×Sector 47.4×
Promoter holding
72.11%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:14 IST BSE
Annual General Meeting

Haleos Labs Annual General Meeting

Haleos Labs Limited announced postal ballot results where shareholders approved director reappointment and related party transactions. However, a resolution for managerial remuneration was rejected by shareholders.

18:07 IST NSE
Annual General Meeting

Haleos Labs Annual General Meeting

Haleos Labs Limited issued a postal ballot notice seeking shareholder approval for director reappointment, managerial remuneration limits, and material related party transactions.

Value
₹190.7 Cr
18:07 IST BSE
Annual General Meeting

Haleos Labs Annual General Meeting

Haleos Labs Limited issued a postal ballot notice for shareholder approval regarding director reappointment, managerial remuneration, and various material related party transactions.

Value
₹200.6 Cr
15:57 IST NSE
Annual General Meeting

Haleos Labs Annual General Meeting

Haleos Labs has announced a postal ballot process to seek shareholder approval for various resolutions, including director reappointment, managerial remuneration, and related party transactions.

01:34 IST BSE
Annual General Meeting

Haleos Labs Annual General Meeting

Haleos Labs Limited shareholders approved a material related party transaction involving a corporate guarantee for RBL Bank. The guarantee secures an External Commercial Borrowing facility for its subsidiary, Mahi Drugs Private Limited. The resolution was passed with a 99.99% majority via postal ballot.